Centogene N.V. Operating Expenses 2011-2026 | CNTG

Annual Operating Expenses Centogene N.V.

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	58 M	42.1 M	30.2 M	21.3 M	19.2 M	-	-	-	-	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
58 M	19.2 M	34.2 M

Operating Expenses of other stocks in the Diagnostics research industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Burning Rock Biotech Limited BNR	726 M	$ 17.1	0.56 %	$ 181 M	China
CareDx, Inc CDNA	411 M	$ 21.5	3.32 %	$ 1.15 B	USA
Accelerate Diagnostics AXDX	77.2 M	-	-61.36 %	$ 2.46 M	USA
Agilent Technologies A	1.99 B	$ 114.52	-0.86 %	$ 34.8 B	USA
Co-Diagnostics CODX	50.6 M	$ 1.55	-	$ 2.06 M	USA
Castle Biosciences CSTL	59.5 M	$ 24.81	1.31 %	$ 689 M	USA
Akumin AKU	778 M	-	-17.87 %	$ 25.9 M	Canada
Biocept BIOC	21.6 M	-	-13.05 %	$ 7.29 M	USA
Aspira Women's Health AWH	13.8 M	-	-6.19 %	$ 10.5 M	USA
Fulgent Genetics FLGT	181 M	$ 14.13	-6.98 %	$ 427 M	USA
ICON Public Limited Company ICLR	408 M	$ 112.85	-4.63 %	$ 9.31 B	Irlanda
Chembio Diagnostics CEMI	28.5 M	-	0.22 %	$ 16.8 M	USA
Oxford Immunotec Global PLC OXFD	59.4 M	-	-	$ 562 M	Britain
Check-Cap Ltd. CHEK	14.1 M	-	-	$ 9.42 M	Israel
Heska Corporation HSKA	131 M	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	24.1 M	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	3.69 B	$ 135.78	7.13 %	$ 21.6 B	USA
Lantheus Holdings LNTH	123 M	$ 85.5	1.04 %	$ 5.77 B	USA
DermTech DMTK	104 M	-	-11.32 %	$ 2.94 M	USA
Global Cord Blood Corporation CO	451 M	-	-	$ 399 M	China
Fluidigm Corporation FLDM	134 M	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	5.91 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	983 M	-	0.12 %	$ 80.1 M	China
Myriad Genetics MYGN	964 M	$ 4.8	1.05 %	$ 444 M	USA
NeoGenomics NEO	430 M	$ 9.44	1.94 %	$ 1.21 B	USA
Medpace Holdings MEDP	118 M	$ 417.54	-0.27 %	$ 12 B	USA
National Research Corporation NRC	38.5 M	$ 17.41	5.77 %	$ 390 M	USA
Charles River Laboratories International CRL	607 M	$ 165.78	-0.71 %	$ 8.22 B	USA
PRA Health Sciences, Inc. PRAH	585 M	-	-	$ 10.7 B	USA
Koninklijke Philips N.V. PHG	7.12 B	$ 26.16	-0.87 %	$ 20 B	Niderland
Enzo Biochem ENZ	47.4 M	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	2.47 B	-	-	$ 19.8 B	USA
Guardant Health GH	226 M	$ 87.6	0.6 %	$ 11 B	USA
Personalis PSNL	44.5 M	$ 5.78	4.71 %	$ 342 M	USA
Motus GI Holdings MOTS	18.6 M	-	-34.28 %	$ 263 K	Israel
Interpace Biosciences IDXG	20 M	$ 2.12	7.07 %	$ 9.38 M	USA
Senseonics Holdings SENS	61.8 M	$ 5.1	-22.84 %	$ 213 M	USA
Soleno Therapeutics SLNO	181 M	$ 52.87	0.09 %	$ 2.69 B	USA
Thermo Fisher Scientific TMO	7.15 B	$ 469.21	-2.04 %	$ 177 B	USA
QIAGEN N.V. QGEN	821 M	-	-	$ 10.6 B	Niderland
Twist Bioscience Corporation TWST	116 M	$ 60.4	3.34 %	$ 3.61 B	USA
Biomerica BMRA	5.64 M	$ 2.19	0.46 %	$ 5.03 M	USA
Laboratory Corporation of America Holdings LH	1.87 B	$ 255.84	-0.37 %	$ 21.3 B	USA
Celcuity CELC	172 M	$ 125.65	3.54 %	$ 5.88 B	USA
Natera NTRA	258 M	$ 207.28	0.54 %	$ 20.4 B	USA
Neogen Corporation NEOG	1.48 B	$ 9.53	1.38 %	$ 2.07 B	USA
Invitae Corporation NVTA	343 M	-	-	$ 21.2 M	USA
Waters Corporation WAT	687 M	$ 307.12	-0.68 %	$ 18.3 B	USA
Quest Diagnostics Incorporated DGX	1.46 B	$ 192.67	-0.79 %	$ 21.4 B	USA